FK506 can inhibit apoptotic cell death induced by the HIV-1 envelope glycoprotein gp120.
Sekigawa
I
I
Hishikawa
T
T
Kaneko
H
H
Hashimoto
H
H
Hirose
S
S
Ingaki
Y
Y
Yamamoto
N
N
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects* / Q000276:immunology / Q000502:physiology; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis; D015699:HIV Envelope Protein gp120 / Q000494:pharmacology*; D015497:HIV-1; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects* / Q000276:immunology / Q000502:physiology; D051379:Mice; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D011994:Recombinant Proteins / Q000494:pharmacology; D012016:Reference Values; D016559:Tacrolimus / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D016207:Cytokines; D015699:HIV Envelope Protein gp120; D011948:Receptors, Antigen, T-Cell; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D016559:Tacrolimus